This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

EZRA M. GREENSPAN, M.D.

AMA Arch Intern Med. 1954;93(6):863-874.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

RECENT reports have stimulated interest in factors responsible for the maintenance of the serum mucoprotein (M) level in health and disease. Winzler and colleagues noted some years ago that a marked increase in the serum M level occurs as a result of inflammatory¹ or neoplastic disease* and after experimental tissue injury.¹ This response in the serum M concentration was presumed to be related to factors of a nonspecific or unknown nature involved in cellular proliferation and tissue breakdown. Several investigators have now demonstrated that divergent changes in the serum mucoprotein (M) level may be observed in patients with certain nosologically or pathologically related diseases. Thus, among the neoplastic diseases, multiple myeloma³ was associated more frequently with a reduction than with an elevation in the serum M concentration. A rising M level was usually observed in the presence of most forms of progressive obstructive biliary tract disease, whereas . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

From the Department of Medicine, The Mount Sinai Hospital, and the National Cancer Institute, National Institutes of Health, United States Public Health Service, Bethesda. Md.

Footnotes
Miss Bernice Gitler gave technical assistance in this study.

This study was supported in part by a grant from the Richard Lewisohn Cancer Research Fund of The Mount Sinai Hospital.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?